Affiliation:
1. Key Laboratory of Synthetic Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China
2. Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai, People's Republic of China
3. Shanghai Collaborative Innovation Center for Biomanufacturing Technology, Shanghai, People's Republic of China
Abstract
ABSTRACT
Pristinamycin I (PI), produced by
Streptomyces pristinaespiralis
, is a streptogramin type B antibiotic, which contains two proteinogenic and five aproteinogenic amino acid precursors. PI is coproduced with pristinamycin II (PII), a member of streptogramin type A antibiotics. The PI biosynthetic gene cluster has been cloned and characterized. However, thus far little is understood about the regulation of PI biosynthesis. In this study, a TetR family regulator (encoded by
SSDG_03033
) was identified as playing a positive role in PI biosynthesis. Its homologue, PaaR, from
Corynebacterium glutamicum
serves as a transcriptional repressor of the
paa
genes involved in phenylacetic acid (PAA) catabolism. Herein, we also designated the identified regulator as PaaR. Deletion of
paaR
led to an approximately 70% decrease in PI production but had little effect on PII biosynthesis. Identical to the function of its homologue from
C. glutamicum
, PaaR is also involved in the suppression of
paa
expression. Given that phenylacetyl coenzyme A (PA-CoA) is the common intermediate of the PAA catabolic pathway and the biosynthetic pathway of
l
-phenylglycine (
l
-Phg), the last amino acid precursor for PI biosynthesis, we proposed that derepression of the transcription of
paa
genes in a Δ
paaR
mutant possibly diverts more PA-CoA to the PAA catabolic pathway, thereby with less PA-CoA metabolic flux toward
l
-Phg formation, thus resulting in lower PI titers. This hypothesis was verified by the observations that PI production of a Δ
paaR
mutant was restored by
l
-Phg supplementation as well as by deletion of the
paaABCDE
operon in the Δ
paaR
mutant. Altogether, this study provides new insights into the regulation of PI biosynthesis by
S. pristinaespiralis
.
IMPORTANCE
A better understanding of the regulation mechanisms for antibiotic biosynthesis will provide valuable clues for
Streptomyces
strain improvement. Herein, a TetR family regulator PaaR, which serves as the repressor of the transcription of
paa
genes involved in phenylacetic acid (PAA) catabolism, was identified as playing a positive role in the regulation of pristinamycin I (PI) by affecting the supply of one of seven amino acid precursors,
l
-phenylglycine, in
Streptomyces pristinaespiralis
. To our knowledge, this is the first report describing the interplay between PAA catabolism and antibiotic biosynthesis in
Streptomyces
strains. Considering that the PAA catabolic pathway and its regulation by PaaR are widespread in antibiotic-producing actinomycetes, it could be suggested that PaaR-dependent regulation of antibiotic biosynthesis might commonly exist.
Publisher
American Society for Microbiology
Subject
Molecular Biology,Microbiology
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献